Table 3.
Focal PSM vs negative SMs |
Non-focal PSM vs negative SMs |
|||
---|---|---|---|---|
Variable | OR (95%CI) | P | OR (95%CI) | P |
Clinical/perioperative model | ||||
BMI | 0.915 (0.859–0.975) | 0.006 | ||
BPC | 1.012 (1.002–1.022) | 0.014 | 1.021 (1.009–1.033) | <0.001 |
ePLND | ||||
No | Ref. | |||
Yes | 1.338 (0.878–2.039) | 0.176 | ||
Surgeon volume | ||||
Low | Ref. | |||
High | 0.577 (0.388–0.859) | 0.007 | ||
Final overall model* | ||||
BMI | 0.914 (0.857–0.974) | 0.006 | ||
BPC | 1.011 (1.002–1.021) | 0.015 | 1.013 (1.000–1.023) | 0.044 |
Pathological T stage | ||||
pT2 | Ref. | Ref. | ||
pT3a | 2.064 (1.145–3.722) | 0.016 | 4.832 (2.348–9.943) | <0.001 |
pT3b | 2.15 (1.196–3.864) | 0.010 | 5.153 (2.541–10.450) | 0.001 |
Surgeon volume | ||||
Low | Ref | |||
High | 0.574 (0.385–0.855) | 0.006 |
*adjusted ORs.